Danetz Jeffrey S, Cassano Anthony D, Stoner Michael C, Ivatury Rao R, Levy Mark M
Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0108, USA.
J Vasc Surg. 2005 Feb;41(2):246-54. doi: 10.1016/j.jvs.2004.11.026.
Penetrating injuries to the axillary and subclavian vessels are a source of significant morbidity and mortality. Although the endovascular repair of such injuries has been increasingly described, an algorithm for endovascular versus conventional surgical repair has yet to be clearly defined. On the basis of institutional endovascular experience treating vascular injuries in other anatomic locations, we defined an algorithm for the management of axillosubclavian vascular injuries. Subsequently, a near decade long experience with the management of axillosubclavian vascular injuries was retrospectively analyzed, so as to more accurately assess the true feasibility of endovascular treatment in these patients.
We defined a management algorithm that included (1) indications, (2) relative contraindications, and (3) strict contraindications for the endovascular repair of axillosubclavian vascular injuries. Anatomic indications for endovascular repair were restricted to relatively limited axillosubclavian injuries (pseudoaneurysms, arteriovenous fistulas, first-order branch vessel injuries, intimal flaps, and focal lacerations). Relative contraindications for endovascular repair included injury to the axillary artery's third portion, substantial venous injury (eg, transection), refractory hypotension, and upper extremity compartment syndrome with neurovascular compression. Strict contraindications to endovascular repair included long segmental injuries, injuries without sufficient proximal or distal vascular fixation points, and subtotal/total arterial transection. Within the context of these definitions, we retrospectively reviewed 46 noniatrogenic subclavian and axillary vascular injuries in 45 patients identified by a prospectively maintained computer registry during a 9-year period. Presentations were reviewed concurrently by two endovascular surgeons, and potential candidates for endovascular management were defined.
Among 46 total case presentations and among the 40 patients who maintained vital signs on presentation, 17 were potentially treatable with endovascular therapy. Among the cohort of 40 presentations, the most common contraindications to endovascular therapy were hemodynamic instability (n = 10), vessel transection (n = 7), and no proximal vascular fixation site (n = 3).
Despite growing enthusiasm for endovascular repair of injuries to the axillary and subclavian vessels, realistic clinical presentation and anatomic locations restrict the broad application of this technique at present. In our experience, less than but approaching 50% of all injuries encountered could be addressed with an endovascular approach. This percentage will increase during the upcoming decades if the endovascular technologies available in hybrid endovascular operating rooms uniformly improve.
腋血管和锁骨下血管穿透伤是导致严重发病和死亡的原因。尽管此类损伤的血管腔内修复已有越来越多的报道,但血管腔内修复与传统手术修复的算法尚未明确界定。基于本机构在其他解剖部位治疗血管损伤的血管腔内经验,我们制定了一套腋锁骨下血管损伤的处理算法。随后,我们对近十年的腋锁骨下血管损伤处理经验进行了回顾性分析,以便更准确地评估血管腔内治疗在这些患者中的真正可行性。
我们制定了一种处理算法,包括(1)腋锁骨下血管损伤血管腔内修复的适应证、(2)相对禁忌证和(3)绝对禁忌证。血管腔内修复的解剖学适应证仅限于相对局限的腋锁骨下损伤(假性动脉瘤、动静脉瘘、一级分支血管损伤、内膜瓣和局灶性撕裂伤)。血管腔内修复的相对禁忌证包括腋动脉第三段损伤、严重静脉损伤(如横断)、难治性低血压以及伴有神经血管受压的上肢骨筋膜室综合征。血管腔内修复的绝对禁忌证包括长节段损伤、没有足够近端或远端血管固定点的损伤以及动脉大部/完全横断。在此定义范围内,我们回顾性分析了在9年期间通过前瞻性维护的计算机登记系统确定的45例患者中的46例非医源性锁骨下和腋血管损伤。两位血管腔内外科医生同时对病例表现进行了评估,并确定了血管腔内治疗的潜在候选者。
在46例病例表现中,以及在40例就诊时生命体征稳定的患者中,17例可能适合血管腔内治疗。在40例病例表现中,血管腔内治疗最常见的禁忌证是血流动力学不稳定(n = 10)、血管横断(n = 7)和没有近端血管固定点(n = 3)。
尽管对腋血管和锁骨下血管损伤的血管腔内修复的热情日益高涨,但目前实际的临床表现和解剖位置限制了该技术的广泛应用。根据我们的经验,所有遇到的损伤中不到但接近50%可以采用血管腔内方法处理。如果杂交血管腔内手术室现有的血管腔内技术得到统一改进,在未来几十年这个比例将会增加。